Understanding FVC in Pulmonary Fibrosis: What Your Numbers Mean
Forced Vital Capacity (FVC) is the single most important measurement in idiopathic pulmonary fibrosis. It determines disease staging, treatment decisions, transplant eligibility, and prognosis. Understanding what FVC measures, what the numbers mean, and how fast they typically change is essential for every IPF patient.
What FVC Measures
FVC measures the total volume of air a person can forcibly exhale after taking the deepest possible breath. The test is performed using a spirometer. The patient breathes in fully, then blows out as hard and as long as possible into the device. The result is reported in liters (absolute FVC) and as a percentage of the predicted value for a person of the same age, sex, and height (FVC % predicted).
In IPF, the scarring (fibrosis) of lung tissue makes the lungs stiff and less able to expand. This reduces the total volume of air the lungs can hold. As fibrosis progresses, FVC declines.
Normal FVC Ranges
A healthy adult typically has an FVC of 3 to 5 liters, depending on age, sex, and height. When expressed as a percentage of predicted, a normal FVC is 80% or higher. Values between 70% and 80% are mildly reduced. Below 50% indicates severe restriction.
| FVC % Predicted | Classification | What It Means for IPF |
|---|---|---|
| 80% or higher | Normal range | Early-stage or pre-symptomatic. Many IPF patients are diagnosed in this range. |
| 70% to 79% | Mildly reduced | Mild disease. Breathlessness may be noticeable during exertion. |
| 50% to 69% | Moderately reduced | Moderate disease. Daily activities become more difficult. Supplemental oxygen may be needed. |
| Below 50% | Severely reduced | Advanced disease. Lung transplant evaluation should be considered. Significant disability. |
How Fast FVC Typically Declines
Without treatment, FVC in IPF patients declines by approximately 150 to 250 mL per year. This translates to roughly 5% to 10% of predicted value per year, though the rate varies significantly between patients.
With nintedanib or pirfenidone, the decline is slowed to approximately 75 to 125 mL per year. With nerandomilast, early data suggests the decline may be slowed further.
The rate of decline is not constant. Some patients experience periods of relative stability followed by sudden drops. An acute exacerbation (a rapid, severe worsening) can cause FVC to drop by 10% or more in a matter of weeks.
What a 10% Decline Means
A decline of 10% or more in FVC over 6 to 12 months is considered clinically significant. It is associated with a 2 to 3 fold increase in mortality risk over the following year. This threshold is used in clinical trials as a primary endpoint and in clinical practice as a trigger for treatment changes or transplant referral.
Even a 5% decline over 6 months carries prognostic significance and may warrant a discussion with the treating physician about adjusting therapy.
FVC vs DLCO
DLCO (diffusing capacity of the lungs for carbon monoxide) is another important lung function measurement in IPF. While FVC measures air volume, DLCO measures how efficiently gases transfer from the lungs into the bloodstream. In IPF, DLCO often declines before FVC, making it an earlier marker of disease progression.
However, FVC remains the primary endpoint in clinical trials and the most widely used metric for tracking disease because it is more reproducible and less affected by technical factors.
How to Track FVC Over Time
Most IPF patients undergo pulmonary function testing every 3 to 6 months. Tracking FVC trends over time is more informative than any single measurement. A single low reading may reflect a bad day, a respiratory infection, or poor test technique. The trend over 3 or more measurements reveals the true trajectory.
PF-Atlas includes an FVC Tracker that allows patients to enter their spirometry results over time and see the trend plotted against population-level decline rates. The tracker also projects future FVC based on the observed rate of decline and compares the trajectory with and without various treatments.
When to Act on FVC Changes
Contact a pulmonologist promptly if FVC drops by 5% or more between two consecutive measurements, if breathlessness worsens suddenly, or if new symptoms (fever, rapid breathing, new cough) develop. These may indicate an acute exacerbation requiring immediate treatment.
The Emergency Protocol section of PF-Atlas provides step-by-step guidance for acute exacerbation response.
Track Your FVC
Enter your spirometry results and see your FVC trajectory over time.
Open FVC Tracker